Workflow
国泰海通证券股份有限公司
icon
Search documents
和元生物2年1期亏 2022年上市募13.23亿国泰海通保荐
Zhong Guo Jing Ji Wang· 2025-08-21 07:30
Group 1 - The company reported a revenue of 120 million yuan in the first half of 2025, representing a year-on-year increase of 6.01% [1] - The net profit attributable to shareholders was -105 million yuan, an improvement from -113 million yuan in the same period last year [1] - The net cash flow from operating activities was -88.5 million yuan, compared to -115 million yuan in the previous year [1] Group 2 - In 2024, the company achieved a revenue of 248 million yuan, marking a year-on-year growth of 21.16% [2][3] - The net profit attributable to shareholders for 2024 was -322 million yuan, worsening from -128 million yuan in the previous year [2][3] - The net cash flow from operating activities was -61 million yuan, an improvement from -90 million yuan in the previous year [2][3] Group 3 - The company was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on March 22, 2022, with an initial public offering of 100 million shares at a price of 13.23 yuan [3] - The total amount raised from the IPO was 1.323 billion yuan, with a net amount of 1.197 billion yuan after expenses [4] - The company announced a capital increase of 0.3 shares for every share held, resulting in a total share capital of 641.15 million shares after the distribution [5]
银华科创指数增强ETF成立 规模12亿元
Zhong Guo Jing Ji Wang· 2025-08-21 03:10
中国经济网北京8月21日讯 今日,银华基金发布关于银华上证科创板综合增强策略交易型开放式指 数证券投资基金基金合同生效公告。 募集期间净认购金额1,211,636,000.00元,认购资金在募集期间产生的利息68,951.81元,募集份额合 计1,211,636,000.00份。 基金经理张凯2009年7月加入银华基金,历任量化投资部金融工程助理分析师、基金经理助理、总 监助理,现任量化投资部副总监、基金经理。 | 基金名称 | 银华上证科创板综合增强策略交易型开放式指数证券投资基 | | --- | --- | | | 金 | | 基金间称 | 科综指增(扩位简称:科创指数增强 ETF) | | 基金主代码 | 0688880 | | 基金运作方式 | 交易型开放式 | | 基金合同生效 | 2025年8月20日 | | 日 | | | 基金管理人名 | 银华基金管理股份有限公司 | | 称 | | | 基金托管人名 | 国泰海通证券股份有限公司 | | 称 | | | 公告依据 | 《中华人民共和国证券投资基金法》、《公开募集证券投资 | | | 基金运作管理办法》等法律法规以及《银华上证科创板综合 | ...
机构风向标 | 喜临门(603008)2025年二季度已披露持仓机构仅8家
Xin Lang Cai Jing· 2025-08-21 01:08
外资态度来看,本期较上一季未再披露的外资机构即香港中央结算有限公司。 2025年8月21日,喜临门(603008.SH)发布2025年半年度报告。截至2025年8月20日,共有8个机构投资者 披露持有喜临门A股股份,合计持股量达1.51亿股,占喜临门总股本的40.65%。其中,机构投资者包括 浙江华易智能制造有限公司、绍兴市越城区华瀚股权投资合伙企业(有限合伙)、全国社保基金四一三组 合、国泰海通证券股份有限公司、国信证券股份有限公司、陕西省国际信托股份有限公司-陕国投·金玉 201号证券投资集合资金信托计划、深圳市景泰利丰投资发展有限公司-景泰星牛7号(定制)私募证券投资 基金、前海开源再融资股票,机构投资者合计持股比例达40.65%。相较于上一季度,机构持股比例合 计下跌了0.28个百分点。 公募基金方面,本期较上一季未再披露的公募基金共计2个,包括融通稳健增长一年持有期混合A、融 通通鑫灵活配置混合。 ...
济民健康龙虎榜数据(8月20日)
济民健康(603222)今日涨停,全天换手率31.31%,成交额18.28亿元,振幅19.56%。龙虎榜数据显示, 营业部席位合计净买入6344.57万元。 上交所公开信息显示,当日该股因日振幅值达19.56%、日换手率达31.31%上榜,营业部席位合计净买 入6344.57万元。 | 买/ | 会员营业部名称 | 买入金额(万 | 卖出金额(万 | | --- | --- | --- | --- | | | | 元) | 元) | | 买一 | 国泰海通证券股份有限公司总部 | 6791.60 | | | | 摩根大通证券(中国)有限公司上海银城中路证券营业部 | 5517.14 | | | 买三 | 高盛(中国)证券有限责任公司上海浦东新区世纪大道证券 营业部 | 3992.07 | | | 卖 买二 | | | | 证券时报·数据宝统计显示,上榜的前五大买卖营业部合计成交4.08亿元,其中,买入成交额为2.36亿 元,卖出成交额为1.72亿元,合计净买入6344.57万元。 具体来看,今日上榜营业部中,第一大买入营业部为国泰海通证券股份有限公司总部,买入金额为 6791.60万元,第一大卖出营业部为浙商 ...
龙虎榜 金田股份上涨9.99%,知名游资海通上海静安区新闸路卖出7995.76万元
Jin Rong Jie· 2025-08-20 10:00
8月20日,金田股份上涨9.99%登上龙虎榜,日振幅值达15%,知名游资卖出。 买入金额最大的前5名营业部 买入额/万 卖出额/万 净额/万 沪股通专用 23051.70 0.00 23051.7 华源证券 股份有限公司江苏分公司 7381.15 0.00 7381.15 国泰海通证券股份有限公司上海松江区中山东路证券营 业部 7078.78 0.00 7078.78 国泰海通证券股份有限公司宜昌沿江大道证券营业部 6745.56 0.00 6745.56 华 林证券股份有限公司北京分公司 5491.16 0.00 5491.16 卖出金额最大的前5名营业部 买入额/万 卖出额/万 净额/万 沪股通专用 0.00 15470.60 -15470.6 国泰海通证券股份有限公司成都北一环路证券营业部 0.00 10901.50 -10901.5 国泰海通证券股份有限公司上海静安区新闸路证券营业部 0.00 7995.76 -7995.76 国泰 海通证券股份有限公司上海浦东新区海阳西路证券营业部 0.00 7849.01 -7849.01 中信证券股份有限公司 上海分公司 0.00 7740.10 -7740.1 ...
和元生物跌3.12% 2022年上市国泰海通保荐
Zhong Guo Jing Ji Wang· 2025-08-20 08:05
Group 1 - The stock of He Yuan Bio (688238.SH) closed at 8.07 yuan, with a decline of 3.12%, currently in a state of breaking issue [1] - He Yuan Bio was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on March 22, 2022, with an initial public offering of 100 million shares at a price of 13.23 yuan [1] - The total amount raised from the IPO was 1.323 billion yuan, with a net amount of 1.197 billion yuan after expenses [1] Group 2 - The total issuance costs for He Yuan Bio's IPO amounted to 126 million yuan, including underwriting fees of 93.795 million yuan [2] - The company announced a capital increase plan, distributing 0.3 shares for every share held, resulting in an increase of 14,795,670 shares, bringing the total share count to 641,145,700 shares [2] - The ex-rights date for the capital increase was set for May 30, 2023 [2]
药明康德跌6.93% 年内高点位置17家券商唱多
Zhong Guo Jing Ji Wang· 2025-08-19 09:03
Group 1 - The stock price of WuXi AppTec (603259.SH) closed at 90.26 yuan, reflecting a decline of 6.93% [1] - On July 30, WuXi AppTec's stock reached its highest point of the year at 102.49 yuan [2] - Between July 29 and July 31, a total of 17 brokerage firms issued positive research reports on WuXi AppTec [2]
智翔金泰跌3.42% 2023年上市募34.7亿国泰海通保荐
Zhong Guo Jing Ji Wang· 2025-08-19 08:44
Core Points - Zhixiang Jintai (688443.SH) closed at 33.05 yuan, with a decline of 3.42%, currently in a state of breaking issue [1] - The company was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on June 20, 2023, with a public offering of 91.68 million shares at an issue price of 37.88 yuan per share [1] - The total amount raised from the initial public offering (IPO) was 347.28 million yuan, with a net amount of 329.14 million yuan after deducting issuance costs, which is 68.86 million yuan less than the originally planned amount [1] - The company aimed to raise 398 million yuan for projects including the expansion of the antibody industrialization base, research and development of antibody drugs, and to supplement working capital [1] Financial Summary - The total issuance costs for the IPO amounted to 18.14 million yuan (excluding tax), with underwriting fees accounting for 16.50 million yuan [2]
关于新增国泰海通证券股份有限公司为部分基金流动性服务商的公告
Group 1 - The announcement states that to enhance the market liquidity and stable operation of specific index funds, a new liquidity service provider, Guotai Junan Securities Co., Ltd., will be added starting from August 19, 2025 [1][2] - The funds mentioned include the Huaxia CSI All Share Public Utilities ETF (159301), Huaxia CSI Power Grid Equipment Theme ETF (159326), and Huaxia CSI All Share Transportation ETF (159666) [1]
嘉诚国际: 关于变更持续督导保荐代表人的公告
Zheng Quan Zhi Xing· 2025-08-18 16:21
Core Viewpoint - The company announces a change in its sponsor representative due to the departure of Liu Xiangmao, with Zhang Chenghao appointed to continue the supervisory duties [1]. Group 1 - The company expresses gratitude to Liu Xiangmao for his contributions during his tenure as the sponsor representative [1]. - The new sponsor representatives are Fang Zilong and Zhang Chenghao [1]. - The change is communicated to ensure the orderly continuation of supervisory work [1]. Group 2 - Zhang Chenghao holds a master's degree in finance and has experience in various projects, including private placements and advisory roles for companies undergoing restructuring [3]. - He has a good record of compliance with relevant regulations in the sponsorship business [3].